benzylpenicillin panpharma pulver till injektions-/infusionsvätska, lösning
panpharma sa - bensylpenicillinnatrium - pulver till injektions-/infusionsvätska, lösning - bensylpenicillinnatrium 1 g aktiv substans - bensylpenicillin
benzylpenicillin fresenius kabi 0,6 g pulver till injektions-/infusionsvätska, lösning
fresenius kabi ab - bensylpenicillinnatrium - pulver till injektions-/infusionsvätska, lösning - 0,6 g - bensylpenicillinnatrium 0,6 g aktiv substans
benzylpenicillin fresenius kabi 1,2 g pulver till injektions-/infusionsvätska, lösning
fresenius kabi ab - bensylpenicillinnatrium - pulver till injektions-/infusionsvätska, lösning - 1,2 g - bensylpenicillinnatrium 1,2 g aktiv substans
benzylpenicillin fresenius kabi 3 g pulver till injektions-/infusionsvätska, lösning
fresenius kabi ab - bensylpenicillinnatrium - pulver till injektions-/infusionsvätska, lösning - 3 g - bensylpenicillinnatrium 3 g aktiv substans
benzylpenicillin fresenius kabi 6 g pulver till injektions-/infusionsvätska, lösning
fresenius kabi ab - bensylpenicillinnatrium - pulver till injektions-/infusionsvätska, lösning - 6 g - bensylpenicillinnatrium 6 g aktiv substans
benzylpenicillin vetcare 600 mg intramammär suspension
vetcare ltd. - bensylpenicillinprokainmonohydrat - intramammär suspension - 600 mg - bensylpenicillinprokainmonohydrat 600 mg aktiv substans; metylparahydroxibensoat hjälpämne; cetostearylalkohol hjälpämne; propylparahydroxibensoat hjälpämne - prokainbensylpenicillin - nöt
aubagio
sanofi winthrop industrie - teriflunomide - multipel skleros - selektiva immunsuppressiva medel - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - multipel skleros, skovvis förlöpande - immunsuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - multipel skleros, skovvis förlöpande - immunsuppressiva, selektiva immunsuppressiva - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
teriflunomide newbury 14 mg filmdragerad tablett
newbury pharmaceuticals ab - teriflunomid - filmdragerad tablett - 14 mg - teriflunomid 14 mg aktiv substans; laktosmonohydrat hjälpämne